Companies: 10,795·Total market cap: $144.5T
Evotec SE

Evotec SE

EVOTFOTCHealthcare● Active
$6.69
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio
52W High$8.58
52W Low$4.725
Overview

Evotec SE(EVOTF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · EVOTF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.09evotf eps ttm · evotf earnings per shareEarnings history
PE Ratio (TTM)evotf pe ratio ttm · evotf price to earningsPE Ratio deep dive
Revenue (TTM)$745.5Mevotf revenue ttm · evotf annual revenueFull revenue history
Dividend Yield不分红does evotf pay dividends · evotf dividend yieldDividend history
Shares Outstanding177.6Mevotf shares outstanding · evotf floatShares outstanding history
Next EarningsAug 13, 2026Est.evotf earnings date · evotf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$788.1M▼ 1.12% YoY
202320242025
evotec se revenue · evotf revenue 2025
FY 2025Net Income-$103.5M▲ +47.23% YoY
202320242025
evotec se net income · evotf profit 2025
FY 2025EPS$-0.58▲ +47.75% YoY
202320242025
evotf eps · evotec se earnings per share 2025
TTM:Revenue: $745.5MNet Income: -$194.3MEPS: $-1.09View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy6 位分析师is evotf a buy · evotf analyst rating
Strong Buy
0
Buy
3
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$6.69Current
$Avg Target
$High
evotf price target · evotf 12 month forecast

合计: 6 · 买入占比: 50.0%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M-16.48%
YTD-16.48%
1Y-19.11%
5Y-84.63%

关于 Evotec SE

CEOChristian Wojczewski
IPO DateOct 7, 2009
Employees4,766
CountryDE
Websiteevotec.com

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas…

what is evotec se · evotf stock overview · evotec se company profile · who is evotec se ceo · evotf OTC · evotec se headquarters · evotec se business segments

关于股票概览与关键数据

Evotec SE(EVOTF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Oct 7, 2009 在 OTC 上市。截至最近交易日,EVOTF 股价为 $6.69,市值约为 $1.2B。过去12个月累计回报 -19.11%,年初至今回报 -16.48%。

根据 6 位华尔街分析师,Evotec SE 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Evotec SE 营收 $788.1M,净利润 -$103.5M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Evotec SE(EVOTF)股价为 $6.69,在 OTC 上市,52周区间为 $4.72 – $8.58。

EVOTF 最新股价EVOTF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议